ROS1-rearranged non-small cell lung carcinoma

From Libre Pathology
Revision as of 02:15, 31 December 2019 by Michael (talk | contribs) (create)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

ROS1-rearranged non-small cell lung carcinoma is a subtype of non-small cell lung carcinoma that can be treated with inhibitors that significantly prolong survival.[1]

See also

References

  1. ↑ Shaw, AT.; Ou, SH.; Bang, YJ.; Camidge, DR.; Solomon, BJ.; Salgia, R.; Riely, GJ.; Varella-Garcia, M. et al. (Nov 2014). "Crizotinib in ROS1-rearranged non-small-cell lung cancer.". N Engl J Med 371 (21): 1963-71. doi:10.1056/NEJMoa1406766. PMID 25264305.
Retrieved from "https://librepathology.org/w/index.php?title=ROS1-rearranged_non-small_cell_lung_carcinoma&oldid=50590"